Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuhua Wan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|November 22, 2019
The Immunogenicity and Anti-tumor Efficacy of a Rationally Designed Neoantigen Vaccine for B16F10 Mouse MelanomaYan Zhang, Zhibing Lin, Yuhua Wan, et al.
Frontiers in Oncology|September 9, 2020
Recombinant KRAS G12D Protein Vaccines Elicit Significant Anti-Tumor Effects in Mouse CT26 Tumor ModelsYuhua Wan, Yan Zhang, Gengchong Wang, et al.
Vaccines|May 20, 2020
Recombinant Costimulatory Fusion Proteins as Functional Immunomodulators Enhance Antitumor Activity in Murine B16F10 MelanomaHuaman Cai, Wenfang Wang, Zhibing Lin, et al.
Cancers|July 27, 2022
Developing ROR1 Targeting CAR-T Cells against Solid Tumors in Preclinical StudiesBoon Kiat Lee, Yuhua Wan, Zan Lynn Chin, et al.
Cell Research|September 23, 2015
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike proteinYan Li, Yuhua Wan, Peipei Liu, et al.
Cell Host & Microbe|September 12, 2014
Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26Qihui Wang, Jianxun Qi, Yuan Yuan, et al.
The Journal of Clinical Investigation|January 13, 2026
T cell receptor-engineered T cells targeting the TP53R248Q neoantigen elicit antitumor effects in human cancer modelsLianghua Shen, Ziyu Chen, Jian Xu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|November 22, 2019
The Immunogenicity and Anti-tumor Efficacy of a Rationally Designed Neoantigen Vaccine for B16F10 Mouse MelanomaYan Zhang, Zhibing Lin, Yuhua Wan, et al.
Frontiers in Oncology|September 9, 2020
Recombinant KRAS G12D Protein Vaccines Elicit Significant Anti-Tumor Effects in Mouse CT26 Tumor ModelsYuhua Wan, Yan Zhang, Gengchong Wang, et al.
Vaccines|May 20, 2020
Recombinant Costimulatory Fusion Proteins as Functional Immunomodulators Enhance Antitumor Activity in Murine B16F10 MelanomaHuaman Cai, Wenfang Wang, Zhibing Lin, et al.
Cancers|July 27, 2022
Developing ROR1 Targeting CAR-T Cells against Solid Tumors in Preclinical StudiesBoon Kiat Lee, Yuhua Wan, Zan Lynn Chin, et al.
Cell Research|September 23, 2015
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike proteinYan Li, Yuhua Wan, Peipei Liu, et al.
Cell Host & Microbe|September 12, 2014
Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26Qihui Wang, Jianxun Qi, Yuan Yuan, et al.
The Journal of Clinical Investigation|January 13, 2026
T cell receptor-engineered T cells targeting the TP53R248Q neoantigen elicit antitumor effects in human cancer modelsLianghua Shen, Ziyu Chen, Jian Xu, et al.
Pageof 1